Organization Overview
Alternative names
Anemia (Phase 3)
Bronchiectasis (Phase 4)
Carcinoma (Phase 2)
Cardiovascular Diseases (Phase 1)
Cartilage Diseases (Phase 2)
Cerebrovascular Disorders (Phase 2)
Cognitive Dysfunction (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Neuropathies (Phase 3)
End Stage Liver Disease (Phase 1)
Fatty Liver (Phase 1)
Glaucoma (Phase 3)
Glaucoma, Open-Angle (Phase 3)
Glucose Intolerance (Phase 3)
Graft vs Host Disease (Phase 2)
Graves Disease (Phase 3)
Hemorrhage (Phase 3)
Hepatitis C (Phase 3)
Hypercholesterolemia (Phase 2)
Hyperlipidemias (Phase 2)
Hyperlipoproteinemias (Phase 2)
Hyperparathyroidism (Phase 4)
Hyperparathyroidism, Secondary (Phase 4)
Hypertension (Phase 3)
Hyperthyroidism (Phase 3)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 3)
Liver Diseases (Phase 1)
Long Term Adverse Effects (Phase 2)
Malaria (Phase 3)
Malaria, Vivax (Phase 3)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 4)
Non-alcoholic Fatty Liver Disease (Phase 1)
Ocular Hypertension (Phase 3)
Pelvic Neoplasms (Phase 2)
Postpartum Hemorrhage (Phase 3)
Prediabetic State (Phase 2)
Renal Insufficiency, Chronic (Phase 3)
Vascular Diseases (Phase 3)